Joe Biden promised he’d bring in a competent, tested team to run the
pandemic response, set ambitious vaccination targets and impose strict
public health guidelines.
His team arrived at the White House with a 200-page response plan ready
to roll out. But instead, they have spent much of the last week trying
to wrap their hands around the mushrooming crisis — a process officials acknowledge has been humbling, and triggered a concerted effort to
temper expectations about how quickly they might get the nation back to
After a week on the job, Biden’s team is still trying to locate upwards
of 20 million vaccine doses that have been sent to states — a mystery
that has hampered plans to speed up the national vaccination effort.
They're searching for new ways to boost production of a vaccine
stockpile that they've discovered is mostly empty. And they're
nervously eyeing a series of new Covid-19 strains that threaten to
derail the response.
“It’s the Mike Tyson quote: ‘Everybody’s got a plan until they get
punched in the mouth,’” said one person with knowledge of the vaccine
effort who’s not authorized to discuss the work. “They are planning.
They are competent. It’s just the weight of everything when you sit
down in that chair. It’s heavy.”
Biden officials leading the coronavirus response launched a series of
regular briefings this week to keep the public informed on the state of
the pandemic and government efforts to contain it and rush vaccines out
to as many Americans as possible.
But the briefings were short on details. And behind the scenes,
officials say, the team was still struggling to get a handle on basic information, liaise with the career government workers who have been
running the response and build out a long-term strategy for bringing —
and then keeping — the virus under control.
“One of the virtues of a well-run transition is that by the time you
take the reins, you have developed some rapport and trust with the
career people you’re working with,” the person familiar with the administration’s work said. The “courtship has been unnaturally short,”
the person added.
“Nobody had a complete picture," said Julie Morita, a member of the
Biden transition team and executive vice president at the Robert Wood
Johnson Foundation. "The plans that were being made were being made
with the assumption that more information would be available and be
revealed once they got into the White House.”
It's a steep challenge that Biden officials said they'd been
anticipating for weeks, amid a rocky transition period that left them scrambling to piece together vaccine distribution plans and coordinate
with state health officials.
Yet in the days since taking over, the Covid response team has
confronted a situation that officials described as far worse than
expected — and that has prompted public assessments so dour they
surprised some who had worked on the administration's former transition
On Tuesday, Biden warned that the "vaccine program is in worse shape
than we anticipated or expected," echoing complaints from his chief of
staff, Ron Klain, that a "plan didn't really exist."
Biden's Covid response team has since made a concerted effort not to
heap blame on the Trump administration, one official said — even as
their vague allusions to a worse-than-expected situation have prompted speculation about what specific problems they've encountered.
But people with knowledge of the response detailed fresh concerns that
are centered largely on the federal government's vaccine supply.
Biden's team is still trying to get a firm grasp on the whereabouts of
more than 20 million doses of Covid-19 vaccine that the federal
government bought and distributed to states but has yet to record as
being administered to patients.
Only a small percentage of those unaccounted for doses — roughly 2
million, two officials said — is due to lags in data reporting, the
Biden team believes. That would mean the rest of the crucial supply is
boxed away in warehouses, sitting idle in freezers or floating
elsewhere in the complex distribution pipeline that runs from the administration to individual states.
That’s a dilemma that predated the Biden team’s arrival, with Biden
himself hammering the vaccine rollout’s first weeks under the Trump administration as a “dismal failure.”
Yet the response team underestimated at the outset how difficult it
would be to fix.
The Biden transition had only received high-level briefings on the
distribution effort in the runup to the inauguration on Jan. 20, a
transition official said, and was largely kept out of detailed
discussions about the on-the-ground operation. The team didn't get
granular access to Tiberius — the central government system used for
tracking vaccine distribution — until the transition's final days.
It was not until after Biden was sworn in that the Covid response team discovered the system was blinded to much of the route that vaccines
traveled from the government's distribution hubs to people's arms.
Instead, once the vaccine shipments are delivered to the states,
responsibility for tracking them has been left up to states’ individual
public health systems. The administration then only gets an update once
the doses are actually administered and an official record is
“I think they were really caught off guard by that,” said one adviser.
“It’s a mess.”
Top Biden officials have stressed that the missing doses are spread out
across the states, which remain largely responsible for getting them to
the health providers charged with vaccinating the tens of millions of
people waiting in line for shots.
But the Covid team has since had to spend hours on the phone with
various state officials trying to manually track down the unused doses,
a time-consuming task that's sapped resources and has yet to give
officials a full picture of where exactly supplies are going.
They've also sought to persuade health providers to stop holding doses
in reserve, a practice borne out of concerns people wouldn't be able to
get the second shot of their two-dose regimen — but one that's no
longer necessary and has only contributed to the confusion, according
to two people with knowledge of the discussions.
On a call with White House officials Tuesday, Arkansas Republican Gov.
Asa Hutchinson vented that some states are bearing the brunt of the
blame for the uneven rollout because of those reserves — a nuance not
reflected in the federal numbers, according to notes of the call
obtained by POLITICO.
The complaint prompted a pledge from Centers for Disease Control and
Prevention Director Rochelle Walensky to issue clearer guidance for how
states should manage their allocated vaccines.
Illinois Democratic Gov. J.B. Pritzker later blamed a Trump
administration program that designated pharmacies to distribute
vaccines to long-term care facilities for “bringing our numbers way
down” because of how slow it has been to get shots in arms.
The White House has since given states permission to seize unused doses
from the pharmacy program and reallocate them elsewhere.
“There is no doubt they are doing a better job,” George Helmy, the
chief of staff for New Jersey Democratic Gov. Phil Murphy, said about
the Biden administration. “We have a true partner who is being
transparent and collaborative.”
As they grapple with the immediate distribution issues, federal
officials have also raced to build out detailed plans for eventually distributing the shots to broader populations beyond health care
workers and older Americans — a project that people familiar with the
effort say the Trump administration never even started on.
And though the Biden team had planned to boost the pace of vaccine manufacturing over time, some Biden officials said they were shocked to
learn soon after Inauguration Day that there was little in the federal
vaccine reserve — and that the companies producing the shots were
nowhere near capable of churning out as many doses as the Trump
administration had projected in the preceding months.
The Biden administration has since warned that supplies will remain
limited until the summer, raising the possibility of ongoing shortages
even as the nation's daily vaccination rate picks up.
The White House cheered promising data on a new single-dose vaccine
from Johnson & Johnson on Friday. But production obstacles have
dampened expectations for its immediate impact, with one federal
official likening the anticipated early flow of shots to "a trickle."
That has turned the Covid team's first days into something closer to a
triage operation than the more orderly rollout that the administration
had hoped for, especially as much of the federal health department
operates on a skeleton staff made up of career officials and a handful
of early political appointees.
And though the Biden administration is still pressing ahead with
building mass vaccination sites and long-planned preparations for the
long-term response effort, officials said the time lost navigating this
early set of difficulties has set back a response already likely to
consume much of Biden's first year in office.
"This isn't over any time soon," said Craig Fugate, a former Obama administration FEMA administrator who worked on the transition. "There
may not be a bright red line where when we cross that line we're done,
we're finished and everything's going to be great."